Literature DB >> 8406194

Epithelial ovarian tumors of borderline malignancy: long-term follow-up.

A C Casey1, D A Bell, J M Lage, A F Fuller, N Nikrui, L W Rice.   

Abstract

Thirty-nine patients underwent primary surgery for epithelial ovarian tumors of low malignant potential at the Massachusetts General Hospital between 1970 and 1980. Eighty-five percent of patients were found to have Stage I disease and 15% were found to have Stage III disease. Fifty-four percent of patients had a tumor with serous histology, 39% had a tumor with mucinous histology, and the remainder of patients had tumors with an endometrioid or mixed-cell type. Second malignancies and benign ovarian tumors were frequently found concomitantly with the borderline tumors or in follow-up. Gastrointestinal and endometrial adenocarcinomas were the most common second malignancies and were frequently found associated with a borderline tumor of serous histology. Follow-up was available in all 39 patients (100%). Mean time of follow-up was 11.8 years. Sixty-nine percent of patients are clinically without evidence of disease with a mean follow-up of 14.7 years, 23% died of other causes, 5% died of disease, and 3% died with disease and sepsis. All patients dying with disease did so within 7.3 years of their primary surgery. Seven patients underwent conservative surgery, defined as preservation of some ovarian tissue. Six of 7 patients are clinically free of disease with a mean follow-up of 14.6 years; 1 patient died of other causes. No patients treated conservatively had a recurrence of their disease.

Entities:  

Mesh:

Year:  1993        PMID: 8406194     DOI: 10.1006/gyno.1993.1218

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

1.  Evaluation of microinvasion and lymph node involvement in ovarian serous borderline/atypical proliferative serous tumors: a morphologic and immunohistochemical analysis of 37 cases.

Authors:  Kruti P Maniar; Yihong Wang; Kala Visvanathan; Ie-Ming Shih; Robert J Kurman
Journal:  Am J Surg Pathol       Date:  2014-06       Impact factor: 6.394

2.  Invasive recurrence of serous borderline ovarian tumor as multifocal lymphadenopathy 25 years after initial diagnosis.

Authors:  Ioannis Alagkiozidis; Sandy Dorcelus; Jonathan Somma; Lee Yi Chun; Ghadir Salame
Journal:  Gynecol Oncol Case Rep       Date:  2012-08-28

3.  Borderline epithelial tumors of the ovary: Experience of 55 patients.

Authors:  Vera Loizzi; Luigi Selvaggi; Luca Leone; Donatella Latorre; Doriana Scardigno; Francescapaola Magazzino; Gennaro Cormio
Journal:  Oncol Lett       Date:  2014-12-02       Impact factor: 2.967

4.  Outcomes of controlled ovarian hyperstimulation/in vitro fertilization for infertile patients with borderline ovarian tumor after conservative treatment.

Authors:  Chan Woo Park; Kwang Moon Yang; Hye Ok Kim; Sung Ran Hong; Tae Jin Kim; Kyung Taek Lim; Ki Heon Lee; Inn Soo Kang
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

5.  Allelic loss at 19q12 and Xq11-12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential.

Authors:  K Nakayama; Y Takebayashi; K Hata; R Fujiwaki; K Iida; M Fukumoto; K Miyazaki
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640

6.  Borderline ovarian tumors: a study of 100 cases from a Tertiary Care Hospital.

Authors:  Ahmet Uysal; Semih Mun; Fatma Uysal; Murat Oztekin; Cem Büyüktosun; Salim Sehirali; Omer Başoğul; Cüneyt E Taner
Journal:  Contemp Oncol (Pozn)       Date:  2013-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.